CLINICAL TRIALS PROFILE FOR VISINE
✉ Email this page to a colleague
All Clinical Trials for VISINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04440280 ↗ | Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy | Recruiting | Massachusetts Eye and Ear Infirmary | Phase 2 | 2020-09-16 | This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye drops decreases oxidative stress and confers cytoprotection in patients with FECD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VISINE
Condition Name
Clinical Trial Locations for VISINE
Trials by Country
Clinical Trial Progress for VISINE
Clinical Trial Phase
Clinical Trial Sponsors for VISINE
Sponsor Name